Global /United States /Healthcare /Drug Manufacturers - Specialty & Generic /NIKA

Nika Pharmaceuticals, Inc.

NIKA

• OTCMKTS: NIKA • Delayed

0.4020USD 0%

As of 13 June 2026, Nika Pharmaceuticals, Inc. has a market cap of $422.78M USD, ranking #16300 globally and #2754 in the United States. It ranks #1470 in the Healthcare sector, and #81 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

16300

Country Rank

2754

Sector Rank

1470

Industry Rank

Key Stats

Market Cap

$422.78MUSD

Enterprise Value

$423.1MUSD

Net Income (TTM)

-$76.4KUSD

PB Ratio

-1420.5

Company Profile

Country (HQ)

United States

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Dimitar Savov open_in_new

Founded

2000

Website

nikapharmaceuticals.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	-45%	-47%	5.8%	25%	5.8%	-60%	-99%	-99%

News

Markets

Exchange	Ticker	Price	Quotes
OTC Markets (OTCMKTS / OTC) MIC: OTCM PRIMARY	NIKA Nika Pharmaceuticals Inc ISIN: US1513411041 Shares Out.: Shares Outstanding: 1.049B¹ Shares Float: 118.96M² TV: TradingView: OTC: NIKA SA: Stock Analysis: OTC: NIKA YF: Yahoo Finance: NIKA GF: Google Finance: OTCMKTS: NIKA BA: Barron's: NIKA MS: Morningstar: PINX: NIKA	0.4020 USD	TV: TradingView: OTC: NIKA SA: Stock Analysis: OTC: NIKA YF: Yahoo Finance: NIKA GF: Google Finance: OTCMKTS: NIKA BA: Barron's: NIKA MS: Morningstar: PINX: NIKA

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Nika Pharmaceuticals, Inc.

Nika Pharmaceuticals, Inc. engages in the development and distribution pharmaceutical products for dietary supplements and antiviral drugs in the United States. The company offers ITV-1, TNG, physiolong, carotilen, fructin, dry boza, anthocylen C, hypocholestin, biodetoxin, silymaron, and solamentum products. The company was formerly known as Centennial Growth Equities Inc. and changed its name to Nika Pharmaceuticals, Inc. in May 2022. Nika Pharmaceuticals, Inc. was incorporated in 2000 and is based in Henderson, Nevada.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (United States)

Name	Market Cap (USD) diff.	PE	Country
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 7K%	-	United States
Indivior PLC LSE: INDV	$2.07B 1.54B GBP 389%	-	United States
Endo, Inc. OTCMKTS: NDOI	$1.8B 326%	0.4	United States
Dynavax Technologies Corp. NASDAQ: DVAX	$1.76B 317%	-	United States
ArriVent BioPharma, Inc. NASDAQ: AVBP	$1.33B 214%	-	United States
BellRing Brands, Inc. NYSE: BRBR	$1.02B 142%	12.1	United States

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$36.75B 108.92B ILS 9K%	24.2	Israel
Zhejiang NHU Company Ltd. SHE: 002001	$15.84B 107.34B CNY 4K%	16.0	China
Cipla Ltd. NSE: CIPLA	$11.16B 1.06T INR 3K%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.04B 1.05T INR 3K%	22.7	India
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.09B 61.6B CNY 2K%	80.6	China
ABIVAX Société Anonyme EPA: ABVX	$8.74B 7.57B EUR 2K%	-	France

chevron_leftBack